<?xml version="1.0" encoding="UTF-8"?>
<p>Hand, foot, and mouth disease (HFMD) has long been a focus of global public health, especially for children aged &lt; 5 years (
 <xref rid="B12" ref-type="bibr">Huang et al., 2018</xref>; 
 <xref rid="B22" ref-type="bibr">Qi et al., 2018</xref>). Enteroviruses (EVs), especially EV-A71 and Coxsackievirus A16 (CVA-16), are the main etiological agents involved in HFMD (
 <xref rid="B26" ref-type="bibr">Solomon et al., 2010</xref>; 
 <xref rid="B5" ref-type="bibr">Chen et al., 2013</xref>). Since around 2014, CVA-10 and a new CVA-6 genotype have also become widespread (
 <xref rid="B4" ref-type="bibr">Chen et al., 2017</xref>; 
 <xref rid="B2" ref-type="bibr">Broccolo et al., 2019</xref>). In the past few years, CVA-16 infection has caused several severe epidemics in Southeast Asia and some Asian countries (
 <xref rid="B19" ref-type="bibr">Liu et al., 2014</xref>; 
 <xref rid="B13" ref-type="bibr">Koh et al., 2016</xref>; 
 <xref rid="B24" ref-type="bibr">Rao et al., 2017</xref>), as well as some European countries (
 <xref rid="B20" ref-type="bibr">Ljubin-Sternak et al., 2011</xref>; 
 <xref rid="B3" ref-type="bibr">Cabrerizo et al., 2014</xref>). In recent years, due to the widespread use of EV-A71 vaccine in China, the rate of HFMD caused by this strain has decreased significantly (
 <xref rid="B6" ref-type="bibr">Chong et al., 2012</xref>; 
 <xref rid="B30" ref-type="bibr">Yi et al., 2017</xref>; 
 <xref rid="B16" ref-type="bibr">Li Y. et al., 2019</xref>). Therefore, CVA-16 was identified as our research focus.
</p>
